Our Services

Pharmaceutical Policy Consulting provides evidence-based technical assistance to strengthen pharmaceutical systems in low and middle-income countries. We focus on:

• developing financing strategies that improve medicine access and use

• designing incentives and disincentives through various payment and purchasing modalities
• efficiency studies on resource use (pharmacoeconomics, financial modeling)
• innovative financing strategies (risk-sharing agreements, cost-sharing agreements, performance-based financing)
• fund flow analysis and financial sustainability
• medicine price analysis and comparisons to inform pricing policy

• monitoring and evaluation of pharmaceutical systems

• program evaluation through applied quantitative and qualitative research methods
• development of progress monitoring systems that enable regular adjustments to planned activities
• embedding research outcomes into decision-making processes
• development of results framework and metrics

• enhancing pharmaceutical sector governance

• build capacity of local  institutions to strengthen transparency and accountability
• stakeholder mapping and engagement processes

• mainstreaming gender in pharmaceutical policy

• assessment of medicines policies from a gender perspective
• developing gender sensitive indicators

Our Products

The outcomes of our technical assistance include:

• pharmaceutical system assessment reports,
• economic and financial models,
• rapid evidence reviews,
• conceptual models for pharmaceutical system improvements,
• cross national and comparative policy analysis,
• monitoring and evaluation tools, and
• situation analysis reports.

Our Skills

Strategy: medicines policy, pricing policy.
Management and planning: project management, financial management, reimbursement negotiation, team leadership, stakeholder engagement.
Technical Analysis: pharmacoeconomic evaluations, pharmaceutical and health policy analysis
Data Analysis Tools: Stata, HLM, SPSS, TreeAge, and Matlab

Contact Us for more details.